Seattle law firm Hagens Berman Sobol Shapiro said it has filed a shareholder lawsuit against CellCyte Genetics, accusing the biotech company and its officers of artificially inflating its stock price ...
Seattle law firm Hagens Berman Sobol Shapiro said it has filed a shareholder lawsuit against CellCyte Genetics, accusing the biotech company and its officers of artificially inflating its stock price ...
CellCyte Genetics Corporation is developing stem cell enabling therapeutic products designed to allow more efficient delivery and significantly increased retention of adult stem cells to diseased ...
The goal of the study is to investigate the efficiency of CellCyte's glycoprotein products in a preclinical model of myocardial infarction (heart attack). "We look forward to working with the ...
The beleaguered Securities & Exchange Commission has brought civil fraud charges against CellCyte Genetics and two ex-executives, nearly two years after Forbes became the first in the media to point ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results